Clinical Trials Logo

Clinical Trial Summary

This study investigates how remitted individuals with past major depressive disorder (MDD) make approach-avoidance decisions and which brain regions are implicated in such decisions. Information collected through MRI and behavioral tasks will be used to predict depressive symptoms in the future.


Clinical Trial Description

The overarching goals of this research are to investigate: (1) neural substrates of approach/avoidance behaviors in remitted MDDs; (2) stress-induced signaling in remitted individuals with past MDD; (3) neural markers that prospectively predict disease course. This will be achieved through an innovative method of using functional magnetic resonance imaging (fMRI) during an approach/avoidance decision-making task. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04325529
Study type Observational
Source Mclean Hospital
Contact Emma Palermo, BA
Phone 617-855-4412
Email ehpalermo@mclean.harvard.edu
Status Recruiting
Phase
Start date January 19, 2021
Completion date December 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT03278756 - Online Cognitive Control Training for Remitted Depressed Patients N/A
Recruiting NCT05557760 - Effects of Booster Sessions on Depression Vulnerability Following Cognitive Control Training N/A
Withdrawn NCT03548519 - Online Contingent Attention Training (OCAT) N/A
Not yet recruiting NCT05579015 - Predicting Illness Trajectories In Fully Remitted Major Depression Using Concurrent TBS/fNIRS N/A
Completed NCT05166798 - Optimal Dose of a Cognitive Control Training for Depression Vulnerability N/A
Completed NCT02407652 - Cognitive Control Training for Remitted Depressed Patients N/A
Recruiting NCT04944758 - Feasibility of Adherence to Light Therapy N/A
Recruiting NCT04864353 - Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder N/A